PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Embryonic stem cells offer new treatment for multiple sclerosis

2014-06-16
(Press-News.org) Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.

The researchers demonstrated that the embryonic stem cell therapy significantly reduced MS disease severity in animal models and offered better treatment results than stem cells derived from human adult bone marrow.

The study was led by ImStem Biotechnology Inc. of Farmington, Conn., in conjunction with UConn Health Professor Joel Pachter, Assistant Professor Stephen Crocker, and Advanced Cell Technology (ACT) Inc. of Massachusetts. ImStem was founded in 2012 by UConn doctors Xiaofang Wang and Ren-He Xu, along with Yale University doctor Xinghua Pan and investor Michael Men.

"The cutting-edge work by ImStem, our first spinoff company, demonstrates the success of Connecticut's Stem Cell and Regenerative Medicine funding program in moving stem cells from bench to bedside," says Professor Marc Lalande, director of the UConn's Stem Cell Institute.

The research was supported by a $1.13 million group grant from the state of Connecticut's Stem Cell Research Program that was awarded to ImStem and Professor Pachter's lab.

"Connecticut's investment in stem cells, especially human embryonic stem cells, continues to position our state as a leader in biomedical research," says Gov. Dannel P. Malloy. "This new study moves us one step closer to a stem cell-based clinical product that could improve people's lives."

The researchers compared eight lines of adult bone marrow stem cells to four lines of human embryonic stem cells. All of the bone marrow-related stem cells expressed high levels of a protein molecule called a cytokine that stimulates autoimmunity and can worsen the disease. All of the human embryonic stem cell-related lines expressed little of the inflammatory cytokine.

Another advantage of human embryonic stem cells is that they can be propagated indefinitely in lab cultures and provide an unlimited source of high quality mesenchymal stem cells – the kind of stem cell needed for treatment of MS, the researchers say. This ability to reliably grow high quality mesenchymal stem cells from embryonic stem cells represents an advantage over adult bone marrow stem cells, which must be obtained from a limited supply of healthy donors and are of more variable quality.

"Groundbreaking research like this furthering opportunities for technology ventures demonstrates how the University acts as an economic engine for the state and regional economy," says Jeff Seemann, UConn's vice president for research.

The findings also offer potential therapy for other autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, and type-1 diabetes, according to Xu, a corresponding author on the study and one of the few scientists in the world to have generated new human embryonic stem cell lines.

There is no cure for MS, a chronic neuroinflammatory disease in which the body's immune system eats away at the protective sheath called myelin that covers the nerves. Damage to myelin interferes with communication between the brain, spinal cord, and other areas of the body. Current MS treatments only offer pain relief, and slow the progression of the disease by suppressing inflammation.

"The beauty of this new type of mesenchymal stem cells is their remarkable higher efficacy in the MS model," says Wang, chief technology officer of ImStem.

The group's findings appear in the current online edition of Stem Cell Reports, the official journal of the International Society for Stem Cell Research. ImStem is currently seeking FDA approval necessary to make this treatment available to patients.

INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Antarctic species dwindle as icebergs batter shores year-round

Antarctic species dwindle as icebergs batter shores year-round
2014-06-16
The Antarctic shore is a place of huge contrasts, as quiet, dark, and frozen winters give way to bright, clear waters, thick with algae and peppered with drifting icebergs in summer. But as the planet has warmed in the last two decades, massive losses of sea ice in winter have left icebergs free to roam for most of the year. As a result, say researchers reporting in the Cell Press journal Current Biology on June 16, boulders on the shallow seabed—once encrusted with a rich assemblage of species in intense competition for limited space—now mostly support a single species. ...

First Canadian Bell palsy guideline

2014-06-16
The first Canadian guideline for Bell palsy, facial weakness or paralysis caused by facial nerve damage, is aimed at helping physicians manage and treat patients during the acute phase as well as recovery. The guideline, published in CMAJ (Canadian Medical Association Journal), is based on the growing body of recent evidence on the condition. Bell palsy is damage to the facial nerve that results in sudden weakness or paralysis of one side of the face. It can come on suddenly with symptoms such as drooping of the face and eyelids, twitching, and others that may include ...

A faster path to optical circuits

2014-06-16
Just as electronic circuits work with electrical charges, optical circuits process pulses of light, which gives them a distinct advantage in terms of speed. Optical technologies are therefore the object of intense research, aiming to develop novel optical devices that can control the flow of light at the nanometer scale. EPFL scientists have developed a new method that can optimally design a widely-used class of optical devices with unprecedented effectiveness. Their designs have been fabricated in the US, at the University of Rochester, and successfully tested in Italy, ...

Discovery of a bud-break gene could lead to trees adapted for a changing climate

Discovery of a bud-break gene could lead to trees adapted for a changing climate
2014-06-16
CORVALLIS, Ore. — Scientists have confirmed the function of a gene that controls the awakening of trees from winter dormancy, a critical factor in their ability to adjust to environmental changes associated with climate change. While other researchers have identified genes involved in producing the first green leaves of spring, the discovery of a master regulator in poplar trees (Populus species) could eventually lead to breeding plants that are better adapted for warmer climates. The results of the study that began more than a decade ago at Oregon State University ...

Study shows chikungunya mutation places several countries at risk of epidemic

2014-06-16
GALVESTON, Texas — For the first time, University of Texas Medical Branch at Galveston researchers were able to predict further adaptations of the chikungunya virus that recently spread from Africa to several continents that will likely result in even more efficient transmission and infection of more people by this virus strain. A key factor in a viruses' potential to sustain its circulation and ultimately cause disease is its ability to adapt to new host environments. The number and complexity of these adaptations is shaped by how hospitable the new host is to a certain ...

Cover the bases: Sports physicals are no substitute for comprehensive checkups

2014-06-16
ANN ARBOR, Mich. – Nearly half of parents say any qualified health care provider – not just a child's usual provider – can do a sports physical, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. One quarter of the 434 parents surveyed in the poll took their child to an alternate location for the most recent sports physical, says Sarah J. Clark, M.P.H. , associate director of the National Poll on Children's Health and associate research scientist in the University of Michigan Department of Pediatrics. Sports physicals ...

C. difficile epidemic should concern not only hospital patients but people at home

2014-06-16
Without proper infection prevention in hospitals, and now homes, the Clostridium difficile bacteria poses a major health threat, cautions a Case Western Reserve University infection control researcher. While mainly a concern in hospitals, cases of the C. difficile infection (or C. diff) are on the rise in the community, according to the Centers for Disease Control and Prevention that has seen increased reports of the infected people who have had no contact with hospital patients with the infection. The CDC reported 7.6 people out of 100,000 who had no contact with people ...

Diabetes distress vs. depression: Are people with type 2 being misdiagnosed?

2014-06-16
June 16, 2014 (San Francisco) – Researchers have long understood there is a strong association between diabetes and depression. But new research presented at the American Diabetes Association's 74th Scientific Sessions® shows that symptoms of depression in people with type 2 diabetes can be significantly reduced through interventions for "diabetes distress," suggesting that much of what is being labeled as depression may not be a co-morbid psychiatric disorder after all, but rather a reaction to living with a stressful, complex disease that is often difficult to manage. ...

Long-term follow-up of diabetes prevention program shows continued reduction in diabetes development

2014-06-16
June 16, 2014 (San Francisco) – Treatments used to decrease the development of type 2 diabetes continue to be effective an average of 15 years later, according to the latest findings of the Diabetes Prevention Program Outcomes Study, a landmark study funded by the National Institutes of Health (NIH). The results, presented at the American Diabetes Association's 74th Scientific Sessions®, come more than a decade after the Diabetes Prevention Program, or DPP, reported its original findings. In 2001, after an average of three years of study, the DPP announced that the study's ...

Many overestimate exercise intensity: York University study

2014-06-16
TORONTO, June 16, 2014 — Do you work out for health benefits and feel you are exercising more than enough? You might be among the many Canadians who overrate how hard they work out or underestimate what moderate intensity exercise means, according to a recent study out of York University's Faculty of Health. "Our study findings suggest that the majority of young and middle-aged to old adults underestimate the intensity of physical activity that is required to achieve health benefits," says Professor Jennifer Kuk, School of Kinesiology and Health Science. "This is worrisome ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Embryonic stem cells offer new treatment for multiple sclerosis